Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer: CHHIP

NCT00392535 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT00392535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00392535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer: CHHIP
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Not applicable
Overall status
Unknown status
Start date
October 18, 2002
Completion date
June 17, 2021
Enrollment
3,216 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer